Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1830

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 1830
---
 determination, the Compensation Committee shall utilize such market standard metrics as it deems
appropriate, including, without limitation, an analysis of cash compensation paid to independent directors of our peer group.

The Compensation Committee shall also have the
power and discretion to determine in the future whether non-employee directors should receive annual or other grants of options to purchase
shares of common stock or other equity incentive awards in such amounts and pursuant to such policies as the Compensation Committee may
determine utilizing such market standard metrics as it deems appropriate, including, without limitation, an analysis of equity awards
granted to independent directors of our peer group.

74

Policies and Practices for Granting Certain Equity Awards

Our policies and practices regarding the granting
of equity awards are carefully designed to ensure compliance with applicable securities laws and to maintain the integrity of our executive
compensation program. The Compensation Committee is responsible for the timing and terms of equity awards to executives and other eligible
employees.

The timing of equity award grants is determined
with consideration to a variety of factors, including but not limited to, the achievement of pre-established performance targets, market
conditions and internal milestones. The Company does not follow a predetermined schedule for the granting of equity awards; instead,
each grant is considered on a case-by-case basis to align with the Company’s strategic objectives and to ensure the competitiveness
of our compensation packages.

In determining the timing and terms of an equity
award, the Board or the Compensation Committee may consider material nonpublic information to ensure that such grants are made in compliance
with applicable laws and regulations. The Board’s or the Compensation Committee’s procedures to prevent the improper use
of material nonpublic information in connection with the granting of equity awards include oversight by legal counsel and, where appropriate,
delaying the grant of equity awards until the public disclosure of such material nonpublic information.

The Company is committed to maintaining transparency
in its executive compensation practices and to making equity awards in a manner that is not influenced by the timing of the disclosure
of material nonpublic information for the purpose of affecting the value of executive compensation. The Company regularly reviews its
policies and practices related to equity awards to ensure they meet the evolving standards of corporate governance and continue to serve
the best interests of the Company and its shareholders. 

Participation of Employee Directors; New
Directors

Unless separately and specifically approved by
the Compensation Committee in its discretion, none of our employee directors shall be entitled to receive any remuneration for service
as a director (other than expense